110 related articles for article (PubMed ID: 3742880)
1. Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia.
Foa R; Lauria F; Lusso P; Raspadori D; Fierro MT; Tazzari PL; Caudana L; Matera L
Clin Exp Immunol; 1986 May; 64(2):392-8. PubMed ID: 3742880
[TBL] [Abstract][Full Text] [Related]
2. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
Smith BR; Rosenthal DS; Ault KA
Exp Hematol; 1985 Mar; 13(3):189-93. PubMed ID: 3884356
[TBL] [Abstract][Full Text] [Related]
3. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
[TBL] [Abstract][Full Text] [Related]
5. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
Griffiths SD; Cawley JC
Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
[TBL] [Abstract][Full Text] [Related]
7. Interferon responsiveness of natural killer cells in type I human diabetes.
Negishi K; Gupta S; Chandy KG; Waldeck N; Kershnar A; Buckingham B; Charles MA
Diabetes Res; 1988 Jan; 7(1):49-52. PubMed ID: 3402165
[TBL] [Abstract][Full Text] [Related]
8. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
Schmidt RE; Bartley G; Levine H; Schlossman SF; Ritz J
J Immunol; 1985 Aug; 135(2):1020-5. PubMed ID: 3924996
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells in Behçet's disease.
Hamzaoui K; Ayed K; Hamza M; Touraine JL
Clin Exp Immunol; 1988 Jan; 71(1):126-31. PubMed ID: 3258201
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytes from patients with hairy cell leukaemia enable the distinction of two separate subpopulations of activated lymphocyte killer cells generated in mixed lymphocyte culture.
Werkmeister JA; Boyd AW; Triglia T; Burns GF
Clin Exp Immunol; 1985 Jul; 61(1):103-8. PubMed ID: 2931219
[TBL] [Abstract][Full Text] [Related]
12. The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen.
Ziegler-Heitbrock HW; Fütterer A; Rumpold H; Kraft D; Munker R; Riethmüller G
Clin Exp Immunol; 1984 Nov; 58(2):470-7. PubMed ID: 6333947
[TBL] [Abstract][Full Text] [Related]
13. Analysis of natural killer cell defects in childhood acute lymphoblastic leukemia.
Yamada S; Miyagawa Y; Komiyama A; Akabane T
Jpn J Clin Oncol; 1984 Mar; 14(1):75-80. PubMed ID: 6608609
[TBL] [Abstract][Full Text] [Related]
14. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
15. Increased number of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased NK activity during human ageing.
Facchini A; Mariani E; Mariani AR; Papa S; Vitale M; Manzoli FA
Clin Exp Immunol; 1987 May; 68(2):340-7. PubMed ID: 3498573
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
17. A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8.
Perussia B; Fanning V; Trinchieri G
J Immunol; 1983 Jul; 131(1):223-31. PubMed ID: 6408172
[TBL] [Abstract][Full Text] [Related]
18. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
[TBL] [Abstract][Full Text] [Related]
19. The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies.
Perussia B; Trinchieri G; Jackson A; Warner NL; Faust J; Rumpold H; Kraft D; Lanier LL
J Immunol; 1984 Jul; 133(1):180-9. PubMed ID: 6233371
[TBL] [Abstract][Full Text] [Related]
20. Cell surface phenotype of a cloned line of human natural killer cells.
Kornbluth J; Flomenberg N; Dupont B
J Immunol; 1982 Dec; 129(6):2831-7. PubMed ID: 6982944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
